BioCatalystWatch
MDWDWorkspace / MDWD / OverviewCompany library
Price
Market cap
Next catalystExpected Q4 2026EscharEx — pressure-ulcer investigator-initiated study · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Upcoming / outlook

EscharEx®

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

EscharEx®

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

PreINDP1P3FilingApproved
Upcoming / outlook

Upcoming / outlook

Other pipelines

MW005

PreINDP1P2P3FilingApproved
MW005

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MDWD SEC archive